Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
The incidence rate is expected to be especially high among young women with alcoholic liver disease.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
But experts advise caution, as the drug may worsen other liver diseases, including viral hepatitis.
From fatty liver disease to cirrhosis to alcoholic hepatitis—here’s what you need to know.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.